* Tabula Rasa HealthCare Inc TRHC.OQ TRHC.O is expected
to show a rise in quarterly revenue when it reports results
* The Moorestown New Jersey-based company is expected to
report
a 18.2% increase in revenue to $91.171 million from $77.1
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Tabula Rasa
HealthCare
Inc is for a loss of 2 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Tabula Rasa
HealthCare Inc is $10.5, above its last closing price
of $10.41.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2023 -0.10 -0.12 0.03 Beat 125.5
Mar. 31 2023 -0.14 -0.14 -0.02 Beat 85.7
Dec. 31 2022 -0.22 -0.06 -0.05 Beat 23.1
Sep. 30 2022 -0.19 -0.11 -0.26 Missed -132.1
Jun. -0.17 -0.12 -0.25 Missed -111.9
30 2022
Mar. 31 2022 -0.16 -0.16 -0.22 Missed -40
Dec. 31 2021 -0.09 -0.08 -0.09 Missed -14.3
Sep. 30 2021 0.02 0.03 -0.04 Missed -218.5
This summary was machine generated October 30 at 13:02 GMT. All
figures in US dollars unless otherwise stated